Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

Judith M. Müller(The Netherlands Cancer Institute), Daniel S. Peeper(Oncode Institute)
Nature Communications
December 15, 2014
Cited by 633


Related Papers